What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His main research concerns Immunology, Internal medicine, Pathology, Dermatomyositis and Myositis.
Many of his studies involve connections with topics such as Polyneuropathy and Immunology.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Endocrinology, Surgery and Stiff person syndrome.
His work carried out in the field of Pathology brings together such families of science as Inflammation and CD8.
His study in Dermatomyositis is interdisciplinary in nature, drawing from both Polymyositis, Autoimmune disease and Clinical trial.
Marinos C. Dalakas usually deals with Myositis and limits it to topics linked to Disease and Intensive care medicine.
His most cited work include:
- Polymyositis and Dermatomyositis (944 citations)
- A Controlled Trial of High-Dose Intravenous Immune Globulin Infusions as Treatment for Dermatomyositis (832 citations)
- Polymyositis, Dermatomyositis, and Inclusion-Body Myositis (806 citations)
What are the main themes of his work throughout his whole career to date?
Marinos C. Dalakas mostly deals with Immunology, Pathology, Internal medicine, Antibody and Inclusion body myositis.
His Immunology research is multidisciplinary, incorporating perspectives in Dermatomyositis and Myositis.
The study of Pathology is intertwined with the study of Inflammation in a number of ways.
His biological study spans a wide range of topics, including Gastroenterology, Endocrinology, Surgery and Stiff person syndrome.
Marinos C. Dalakas interconnects CD8 and Inflammatory myopathy in the investigation of issues within Inclusion body myositis.
His Autoantibody research includes elements of Multiple sclerosis, Autoimmunity and Octapharma.
He most often published in these fields:
- Immunology (46.10%)
- Pathology (26.06%)
- Internal medicine (21.99%)
What were the highlights of his more recent work (between 2013-2021)?
- Immunology (46.10%)
- Antibody (20.39%)
- Autoantibody (13.12%)
In recent papers he was focusing on the following fields of study:
Marinos C. Dalakas focuses on Immunology, Antibody, Autoantibody, Pathology and Rituximab.
His work often combines Immunology and Multifocal motor neuropathy studies.
Eculizumab is closely connected to Immunotherapy in his research, which is encompassed under the umbrella topic of Antibody.
His research investigates the link between Pathology and topics such as Skeletal muscle that cross with problems in Inflammation, Alemtuzumab, Inclusion body myositis and HMGB1.
The study incorporates disciplines such as B cell, Internal medicine, Autoimmune disease and Stiff person syndrome in addition to Rituximab.
His Internal medicine research is multidisciplinary, relying on both Surgery and Oncology.
Between 2013 and 2021, his most popular works were:
- Inflammatory Muscle Diseases (363 citations)
- Intravenous immunoglobulin in neurology—mode of action and clinical efficacy (129 citations)
- Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity (121 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His primary scientific interests are in Immunology, Autoantibody, Myasthenia gravis, Rituximab and Autoimmunity.
Immunotherapy, Antibody, Chronic inflammatory demyelinating polyneuropathy, Eculizumab and Neuroinflammation are the core of his Immunology study.
His Autoantibody research includes themes of Anti-SSA/Ro autoantibodies, Pathology, Cytotoxicity, Epitope mapping and Epilepsy.
His Pathology study incorporates themes from Optic neuritis and Plasmapheresis.
As a part of the same scientific family, Marinos C. Dalakas mostly works in the field of Myasthenia gravis, focusing on Dermatomyositis and, on occasion, Differential diagnosis, Muscle disease, Biopsy and Pathogenesis.
His work deals with themes such as Randomized controlled trial, Surgery and Randomization, which intersect with Rituximab.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
